DENISSE MEJIA: Open Payments
NPI 1972996833 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 34 payments from 12 companies in 2025. Trend: 2023 $367 · 2024 $387 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $170 |
| Abbott Laboratories | 2 | $113 |
| Lilly USA, LLC | 4 | $68 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Corcept Therapeutics | 3 | $50 |
| Exact Sciences Corporation | 2 | $47 |
| Novo Nordisk Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Kerendia, AIRSUPRA, BREZTRI, FREESTYLE LIBRE 3, ZORYVE, MOUNJARO, Korlym, The Cologuard Plus Collection Kit.
Industry payments across NJ — which companies pay providers there.
